Sweden launches bid to host European Medicines Agency
Sweden has submitted an official bid to host the European Medicines Agency (EMA), an EU body that is leaving London following Brexit.
As Britain prepares to leave the European Union, the European Medicines Agency is relocating to another member state.
Almost every state in the continental bloc has expressed an interest in hosting the authority.
According to a report by Politico, most countries have made official visits to the EMA in London, with Denmark pushing particularly hard.
The Danish authorities have visited twice and have had meetings with almost every other EU country to inform them of their plans. At some of the meetings, Prime Minister Lars Løkke Rasmussen himself has taken part.
Sweden, however, is also well-placed to host the Agency, according to the article. There is already a large number of experts working with new drug approvals in Sweden, and at least 50 people are working full time on the relocation efforts.
On Monday, Sweden's government formally announced its bid to host the EMA in northern Stockholm, close to the Karolinska Institutet medical university.
The main strength of the Swedish offer is that we can guarantee a seamless transition without disruptions, by the end of the Brexit negotiations."
However, politicians in southern Sweden have come out in favour of the Danish capital, Copenhagen, receiving the EMA instead of Stockholm, as this would benefit the job market in Skåne more.
"From the region of Skåne, we would like the EMA to be in Denmark, because of work in Skåne and the possibility of life science in Skåne to be a part of this," said Anders Åkesson, vice president on the board of Region Skåne.
The EMA is an important EU Agency, which determines which drugs are allowed to enter the European market. It currently employs some 900 highly-qualified staff.